AMLX
Price
$5.30
Change
+$0.16 (+3.11%)
Updated
May 2, 04:59 PM (EDT)
Capitalization
473.93M
5 days until earnings call
OKYO
Price
$1.34
Change
-$0.23 (-14.65%)
Updated
May 2, 04:58 PM (EDT)
Capitalization
46.24M
94 days until earnings call
Ad is loading...

AMLX vs OKYO

Header iconAMLX vs OKYO Comparison
Open Charts AMLX vs OKYOBanner chart's image
Amylyx Pharmaceuticals
Price$5.30
Change+$0.16 (+3.11%)
Volume$19.52K
Capitalization473.93M
OKYO Pharma
Price$1.34
Change-$0.23 (-14.65%)
Volume$300
Capitalization46.24M
AMLX vs OKYO Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. OKYO commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and OKYO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (AMLX: $5.32 vs. OKYO: $1.36)
Brand notoriety: AMLX and OKYO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 91% vs. OKYO: 45%
Market capitalization -- AMLX: $473.93M vs. OKYO: $46.24M
AMLX [@Biotechnology] is valued at $473.93M. OKYO’s [@Biotechnology] market capitalization is $46.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileOKYO’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than OKYO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 5 TA indicator(s) are bullish while OKYO’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 5 bullish, 5 bearish.
  • OKYO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than OKYO.

Price Growth

AMLX (@Biotechnology) experienced а -0.75% price change this week, while OKYO (@Biotechnology) price change was -9.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.31%. For the same industry, the average monthly price growth was +8.08%, and the average quarterly price growth was -4.73%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

OKYO is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+4.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($474M) has a higher market cap than OKYO($46.2M). AMLX YTD gains are higher at: 40.741 vs. OKYO (18.489).
AMLXOKYOAMLX / OKYO
Capitalization474M46.2M1,026%
EBITDA-290.98MN/A-
Gain YTD40.74118.489220%
P/E Ratio2.69N/A-
Revenue87.4MN/A-
Total Cash177MN/A-
Total Debt1.98MN/A-
TECHNICAL ANALYSIS
Technical Analysis
AMLXOKYO
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 26 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKEMX38.21N/A
N/A
Fidelity Emerging Markets K
JGIRX77.72N/A
N/A
JPMorgan U.S. GARP Equity R5
NWJFX97.89N/A
N/A
Nationwide NYSE Arca Tech 100 Idx InsSvc
AATSX17.52N/A
N/A
Ancora/Thelen Small-Mid Cap S
APLIX11.07N/A
N/A
Cavanal Hill Hedged Equity Income Inv

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+3.50%
XOMAO - AMLX
68%
Closely correlated
-0.79%
IKNA - AMLX
54%
Loosely correlated
+2.46%
XOMAP - AMLX
51%
Loosely correlated
-0.04%
RGNX - AMLX
46%
Loosely correlated
+5.80%
PRME - AMLX
45%
Loosely correlated
-3.45%
More

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and XRTX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and XRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
-12.94%
XRTX - OKYO
28%
Poorly correlated
-3.81%
IGMS - OKYO
27%
Poorly correlated
+0.75%
DYN - OKYO
24%
Poorly correlated
-1.08%
AMLX - OKYO
24%
Poorly correlated
+3.50%
ELDN - OKYO
24%
Poorly correlated
+0.91%
More